Neurocrine Biosciences Inc - Company Profile
Powered by
All the data and insights you need on Neurocrine Biosciences Inc in one report.
- Save hours of research time and resources with
our up-to-date Neurocrine Biosciences Inc Strategy Report
- Understand Neurocrine Biosciences Inc position in the market,
performance and strategic initiatives.
- Gain competitive edge and increase your
chances of success
Neurocrine Biosciences Catalyst Calendar
Proactively evaluate Neurocrine Biosciences Inc’s catalyst impacts to stay ahead of the competition & improve corporate planning. Bolster business development with timely opportunities.
A sample of Neurocrine Biosciences Catalyst Calendar data
Event Date | Event Type | Company Name | Ticker Symbol | Drug Name | Therapy Area | Indication | Source Type |
---|---|---|---|---|---|---|---|
01 Dec 2019 | GDCTWXYZ | Lorem | Lorem | Lorem | WXYZ | Planned | Lorem |
01 Dec 2019 | Phase I Trial Completion | Neurocrine Biosciences Inc; Oregon Health & Science University; PRC Clinical; The Feinstein Institute for Medical Research; University of California San Francisco; Veristat LLC; Voyager Therapeutics Inc | NBIX; VYGR | VYAADC-01 | Central Nervous System | Neurodegenerative Diseases; Parkinson's Disease | Clinical Trial Registry |
01 Nov 2019 | Phase III Trial Initiation | Huntington Study Group Ltd; Neurocrine Biosciences Inc | NBIX | valbenazine tosylate | Central Nervous System | Chorea; Huntington Disease | Clinical Trial Registry |
22 Sep 2019 | Phase I Trial Completion | Neurocrine Biosciences Inc; Parexel International Corp; PPD Inc; Takeda Pharmaceutical Co Ltd | 4502; NBIX | NBI-1065846 | Central Nervous System | Schizophrenia | Clinical Trial Registry |
Feature
Catalyst Calendar provides forecasted drug development milestones within the Pharma industry including expected timing, expected outcomes and possible financial impacts.
Benefit
Access:
- Trial Events for trials conducted globally by a company, university, institute or CRO: Trial Initiation, Trial Completion, Trial Results
- Regulatory Events related to drug filings with regulatory bodies, approvals and commercial launches. This is covered for the US, EU and Japan
- Intellectual Property Events for patent and exclusivity expiry specific to the US, EU and Japan: Constraining Patent Expiry (US/EU/Japan), Drug Expiry (US/EU/Japan), Commercial Launch (US/EU/Japan)
Value
Proactively evaluate companies and catalyst impacts
Stay ahead of the competition & improve corporate planning
Bolster business development with timely opportunities
Premium databases is part of our industry range of products
Have you found what you were looking for? From start-ups to market leaders, uncover what they do and how they do it.
Access more premium companies when you subscribe to Explorer